Oxford Finance LLC

What Oxford Finance LLC does

Oxford Finance LLC is a specialty finance firm founded in 2002 and headquartered in Alexandria, Virginia, that delivers senior secured loans to public and private companies across healthcare, life sciences, healthtech, business services, and SaaS sectors. The firm operates three core lending divisions: Enterprise Lending (hold sizes of $10MM-$350MM targeting VC/sponsor-backed or publicly traded life sciences, healthtech, and SaaS borrowers), Leveraged Lending (lower middle-market businesses with EBITDA of $5MM-$50MM via senior, unitranche, mezzanine, and second lien structures), and Real Estate & ABL (healthcare facility financing for skilled nursing, assisted living, and hospitals, plus a recently launched traditional asset-based lending division). Since inception, Oxford has originated more than $18 billion in loans across over 750 borrowers.

The firm generates revenue primarily through interest payments on its senior secured loan portfolio, with loan structures including interest-only periods, SOFR-based floating rates, fixed rates, and tranched/milestone-based drawdowns. Go-to-market is relationship-driven, with Co-Heads of Enterprise Lending, dedicated business development professionals, and a multi-office U.S. footprint covering Alexandria, San Diego, San Mateo, and additional presence in Boston, Atlanta, and New York. Distribution occurs through direct bilateral negotiations, syndicated arrangements where Oxford often serves as administrative agent, and co-lending partnerships with Hercules Capital, Silicon Valley Bank, and others. International deal flow targets U.S., Canada, the U.K., and select E.U. countries.

Since 2024, Oxford has materially expanded both its product surface and funding base. Operational milestones include the September 2024 close of a $1.2 billion healthcare lending fund, the mid-2025 launch of a traditional ABL division with senior hires from Ares, record leveraged lending commitments exceeding $2.5 billion in 2025, a $600 million senior unsecured note offering at 7.750% maturing in 2031 (May 2026), and a $400 million private asset-backed securitization with an accordion feature expandable to $1 billion (June 2026). Oxford also completed a KBRA-rated securitization (Oxford Finance Funding Trust 2025-1) backed by approximately $533.6 million in healthcare-related loans, signaling institutional capital markets access and ongoing balance sheet optimization.

Name

Oxford Finance LLC

Legal name

Oxford Finance LLC

Website

http://www.oxfordfinance.com

Company type

Private

Founded year

2002

Operating status

Operating

Headcount range

101–250 employees

Short description

Oxford Finance LLC is a specialty finance firm founded in 2002 that provides senior secured loans to healthcare, life sciences, healthtech, SaaS, and business services companies across the U.S., Canada, the U.K., and select E.U. countries, with over $18 billion originated across 750+ borrowers.

Ownership category

akta.pro rank

Product category

Specialty Finance / Commercial Lending

NAICS

Other Financial Investment Activities (5239), Other Investment Pools and Funds (5259)

SIC

Miscellaneous Business Credit Institution (6159), Asset-Backed Securities (6189)

akta.pro primary industry

Specialty Finance / Structured Credit (FSANADAE)

akta.pro secondary industry

Distressed / Opportunistic Credit (FSANADAF)

Keywords

• Specialty finance
• Senior secured loans
• Healthcare lending
• Asset-based lending
• Leveraged lending

Headquarters

HQ city

Alexandria

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure, Others

Revenue model

1. Interest Income from Senior Secured Loans: Oxford Finance generates revenue primarily through interest payments on senior secured loans provided to public and private companies across life sciences, healthcare services, healthtech, business services, and SaaS sectors. The firm structures loans with various terms including interest-only periods, variable or fixed rates (e.g., SOFR-based floating rates), and tranched deployments.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Oxford Finance LLC is a specialty finance firm that delivers senior secured loans and asset-based financing to public and private companies in the healthcare, life sciences, healthtech, SaaS, business services, and lower middle-market sectors. The firm operates three core lending divisions (Enterprise Lending, Leveraged Lending, and Real Estate & ABL) and supplements its balance sheet lending with capital markets activities including senior unsecured note offerings and private asset-backed securitizations. Loan sizes range from $5MM to $350MM per transaction across U.S., Canada, U.K., and select EU markets.

Product overview

Oxford Finance LLC is a specialty finance firm operating three core lending divisions: Enterprise Lending (senior secured loans to life sciences, healthtech, SaaS, and technology companies with hold sizes of $10-350MM), Leveraged Lending (financing to lower middle-market businesses with EBITDA of $5-50MM), and Real Estate & Asset-Based Lending (healthcare facility financing for skilled nursing, assisted living, and hospitals up to $125MM). Beyond traditional lending, Oxford has expanded into capital markets through a $600 million senior note offering and manages an asset-backed securitization platform, and co-led a $1.2 billion healthcare lending fund in September 2024.

Differentiator

Problem solved

Functional benefit

Products and services

• Enterprise Lending Provides senior secured loans to public and private life sciences, healthtech, SaaS, and technology companies. Target transactions include VC/sponsor-backed or publicly traded companies with hold sizes of $10MM to $350MM per deal across the U.S., Canada, U.K., and select E.U. countries. Used for runway extension, buyouts, acquisitions, growth, refinancing, and working capital.
• Leveraged Lending Provides debt financing to lower middle-market businesses with EBITDA of $5MM to $50MM. Products include senior and unitranche term loans, delayed draw term loans, second lien, mezzanine financing, split-collateral, and leveraged recapitalizations for growth, acquisitions, and refinancing. Oxford invests as lead arranger or club participant with hold sizes of $20MM to $250MM per deal.
• Real Estate & Asset-Based Lending Provides financing solutions to healthcare facility owners and operators in acute, post-acute, and specialty segments including skilled nursing, assisted living, memory care, and hospitals. Property types include single asset or portfolios, operator or investor-owned. Transaction sizes range from $5MM to $125MM with tenors up to 5 years. Recently expanded into traditional ABL with the launch of the Asset-Based Lending Division.
• Senior Note Offering Debt capital markets product offering senior unsecured notes to institutional investors to fund the firm's lending activities. Includes a $600 million issuance at 7.750% fixed rate maturing in 2031.
• Asset-Backed Securitization Private placement securitization transaction involving sale of loans from Oxford's balance sheet, with issued rated asset-backed securities and an accordion feature that could increase total transaction size. Oxford Finance Funding Trust 2025-1 secured by approximately $533.6 million in loans to healthcare-related companies.

Named customers8 records

Segments5 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• Kroll Bond Rating Agency (KBRA)coreOthersKBRA assigned preliminary ratings to Oxford Finance Funding Trust 2025-1, a securitization secured by approximately $533.6 million in loans to healthcare-related companies originated by Oxford Finance LLC.

Scale indicators8 records

Recent moves7 records

Expansion highlights5 records

Direct peers

• Hercules Capital: The largest and most established publicly traded specialty finance company focused on venture-backed life sciences, healthcare, and SaaS lending. Directly comparable to Oxford's Enterprise Lending division, with overlapping product set (senior secured, milestone-tranched loans) and joint co-lending relationships on transactions such as Verona Pharma.
• Silicon Valley Bank (a division of First Citizens Bank): Premier life sciences and tech-focused commercial bank that co-lends with Oxford on biotech facilities (ALX Oncology, Viracta). Comparable in product (venture debt, asset-based, life sciences credit) and target borrower base even though it's now part of First Citizens Bank following the 2023 resolution.
• Trinity Capital Inc. Public specialty lender providing debt products to growth-stage companies, including a meaningful life sciences vertical. Comparable in ticket sizes, drawn-revolving structures, and relationship-driven origination, though it spans a broader set of verticals including tech and cleantech.
• SLR Investment Corp. Publicly traded BDC that focuses on senior secured loans to upper-middle-market and sponsor-backed companies. Comparable to Oxford's Leveraged Lending / ABL expansion, particularly its sponsor finance and asset-based lending verticals.
• Horizon Technology Finance: Specialty finance company providing secured loans to venture capital-backed companies in technology, life sciences, and healthtech. Direct overlap with Oxford's Enterprise Lending division in ticket size, structure, and target segment, though smaller in scale.
• Runway Growth Finance Corp. Publicly traded specialty lender providing senior secured loans to growth-stage, venture-backed companies. Highly comparable across target segment, ticket size, and product (revolvers, term loans, milestones) — particularly relevant peer for Oxford's life sciences / healthtech / tech exposures.
• WhiteHorse Capital: Specialty direct lending and ABL manager focused on the lower and middle market, providing senior secured loans and asset-based facilities. Directly comparable to Oxford's Leveraged Lending and Real Estate & ABL divisions, including size-tier ($20M-$250M tickets) and target borrower profile.

Broad incumbents

• Ares Capital Corporation: One of the largest publicly traded BDCs with a broad specialty finance, middle-market direct lending, and asset-based lending platform. Comparable on the leveraged lending and ABL fronts (notably the source of Oxford's new ABL hires), though far more diversified and at much greater scale.
• Golub Capital: Large direct-lending and asset-based lender focused on middle-market borrowers and sponsor-backed transactions. Closely comparable to Oxford's Leveraged Lending and expanding ABL franchise given overlapping product set (unitranche, second lien, ABL) and sponsor coverage.
• Bridge Bank (a division of Western Alliance Bank): Technology and life sciences-focused commercial bank providing venture debt, asset-based lending, and treasury management. Comparable to Oxford on life sciences and healthtech venture lending, though as part of a larger diversified bank holding company (Western Alliance).

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks7 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/oxfordfinance

Revenue estimate

Valuation estimate

Number of profiles

Profiles18 records

Subsidiaries1 record

Funding overview

Funding rounds2 records

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments170 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Oxford Finance LLC